calcium acetate has been researched along with Coronary Artery Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bigazzi, R; Casani, A; Di Giorgio, A; Grazi, G; Manca Rizza, G; Migliori, M; Panichi, V; Paoletti, S; Rosati, A; Ruggeri, M; Scatena, A; Sgambato, A | 1 |
| Barreto, DV; Barreto, Fde C; Canziani, ME; Carvalho, AB; Cuppari, L; Dalboni, MA; Draibe, SA; Jorgetti, V; Miname, M; Moyses, RM; Neves, KR; Santos, RD | 1 |
| Muenz, LR; Qunibi, W | 1 |
| Barreto, DV; Barreto, Fde C; Canziani, ME; Cuppari, L; Dalboni, MA; de Carvalho, AB; Draibe, SA; Jorgetti, V; Miname, M; Moyses, RM; Neves, KR; Santos, RD | 1 |
| Barreto, DV; Barreto, F; Cancela, AL; Canziani, ME; Carvalho, AB; Cuppari, L; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM; Oliveira, RB | 1 |
| Paret, CL | 1 |
| Burke, S; Chasan-Taber, S; Chertow, GM; Ferramosca, E; Raggi, P; Ratti, C | 1 |
| Budoff, MJ; Gao, YL; Kessler, P; Mao, SS; Moustafa, M; Qunibi, W | 1 |
| Budoff, M; Diaz-Buxo, JA; He, DY; Kessler, PD; Moustafa, M; Muenz, LR; Qunibi, W | 1 |
| Dennis, VW; Fatica, RA | 1 |
1 review(s) available for calcium acetate and Coronary Artery Disease
| Article | Year |
|---|---|
Cardiovascular mortality in chronic renal failure: hyperphosphatemia, coronary calcification, and the role of phosphate binders.
Topics: Acetates; Antacids; Calcinosis; Calcium; Calcium Compounds; Coronary Artery Disease; Humans; Kidney; Kidney Failure, Chronic; Phosphates; Polyamines; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors | 2002 |
4 trial(s) available for calcium acetate and Coronary Artery Disease
| Article | Year |
|---|---|
Phosphate binder impact on bone remodeling and coronary calcification--results from the BRiC study.
Topics: Acetates; Bone Remodeling; Brazil; Calcinosis; Calcium Compounds; Chelating Agents; Comorbidity; Coronary Artery Disease; Female; Humans; Incidence; Male; Middle Aged; Polyamines; Renal Dialysis; Sevelamer; Treatment Outcome | 2008 |
Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate.
Topics: Acetates; Adult; Analysis of Variance; Biopsy; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Calcinosis; Calcitriol; Calcium; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Dialysis Solutions; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Follow-Up Studies; Humans; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Polyamines; Sevelamer; Tomography, X-Ray Computed | 2011 |
The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study.
Topics: Acetates; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Failure, Chronic; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Reproducibility of Results; Sevelamer; Tomography, X-Ray Computed; Treatment Outcome | 2008 |
A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
Topics: Acetates; Anticholesteremic Agents; Atorvastatin; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Female; Heptanoic Acids; Humans; Male; Middle Aged; Polyamines; Prospective Studies; Pyrroles; Renal Dialysis; Sevelamer; Time Factors | 2008 |
5 other study(ies) available for calcium acetate and Coronary Artery Disease
| Article | Year |
|---|---|
A pharmacoeconomic analysis of phosphate binders cost-effectiveness in the RISCAVID study.
Topics: Acetates; Aged; C-Reactive Protein; Calcium Carbonate; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Cost-Benefit Analysis; Databases, Factual; Female; Humans; Kidney Failure, Chronic; Male; Markov Chains; Middle Aged; Phosphates; Prospective Studies; Quality-Adjusted Life Years; Renal Dialysis; Sevelamer; Stroke; Survival Analysis; Vitamin D | 2015 |
Association of changes in bone remodeling and coronary calcification in hemodialysis patients: a prospective study.
Topics: Acetates; Adult; Bone Remodeling; Calcinosis; Calcium Compounds; Coronary Artery Disease; Female; Humans; Male; Middle Aged; Polyamines; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2008 |
Progression of calcification in the Calcium Acetate Renagel Evaluation-2 (CARE-2) Study.
Topics: Acetates; Calcinosis; Calcium Compounds; Chelating Agents; Coronary Artery Disease; Disease Progression; Humans; Polyamines; Sevelamer | 2008 |
Calcium-containing phosphate binder use associated with accelerated atherosclerotic coronary calcification.
Topics: Acetates; Calcium; Calcium Compounds; Coronary Artery Disease; Epoxy Compounds; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Infarction; Phosphorus; Polyamines; Polyethylenes; Renal Dialysis; Sevelamer | 2003 |
Potential antiatherogenic and anti-inflammatory properties of sevelamer in maintenance hemodialysis patients.
Topics: Acetates; Aged; Anti-Inflammatory Agents; beta 2-Microglobulin; C-Reactive Protein; Calcium Compounds; Coronary Artery Disease; Disease Progression; Female; Fibrinolytic Agents; Homocysteine; Humans; Kidney Failure, Chronic; Lipoproteins; Male; Middle Aged; Phosphates; Phosphorus Metabolism Disorders; Polyamines; Renal Dialysis; Sevelamer | 2005 |